Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CRVO · NASDAQ · Pharmaceutical Preparations
$1.33−0.12 (−8.28%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
Cervomed (CRVO) · oqro.io/stocks/CRVO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 18, 2026 · Filed Nov 20, 2026
CEO purchased ~$117K of CRVO shares in the open marketSourceInsider trade · Traded Nov 18, 2026 · Filed Nov 20, 2026
CEO purchased ~$36K of CRVO shares in the open marketSourceInsider trade · Traded Jun 11, 2026 · Filed Jun 15, 2026
Director purchased ~$3M of CRVO shares in the open marketSourceInsider trade · Traded Nov 17, 2025 · Filed Nov 19, 2025
CEO purchased ~$91K of CRVO shares in the open marketSourceInsider trade · Traded Nov 17, 2025 · Filed Nov 19, 2025
Director purchased ~$91K of CRVO shares in the open marketSourceInsider trade · Traded Nov 18, 2025 · Filed Nov 19, 2025
CFO purchased ~$21K of CRVO shares in the open marketSourceInsider trade · Traded Nov 17, 2025 · Filed Nov 19, 2025
CEO purchased ~$91K of CRVO shares in the open marketSourceInsider trade · Traded Nov 17, 2025 · Filed Nov 19, 2025
Officer purchased ~$30K of CRVO shares in the open marketSourceInsider trade · Traded Nov 17, 2025 · Filed Nov 19, 2025
Director purchased ~$91K of CRVO shares in the open marketSourceInsider trade · Traded Nov 17, 2025 · Filed Nov 19, 2025
CFO purchased ~$8.4K of CRVO shares in the open marketSourceInsider trade · Traded Nov 18, 2025 · Filed Nov 19, 2025
Officer purchased ~$12K of CRVO shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 17, 2025
CEO purchased ~$33K of CRVO shares in the open marketSourceInsider trade · Traded Nov 14, 2025 · Filed Nov 17, 2025
Officer purchased ~$76K of CRVO shares in the open marketSourceInsider trade · Traded Nov 14, 2025 · Filed Nov 17, 2025
CEO purchased ~$13K of CRVO shares in the open marketSourceInsider trade · Traded Nov 14, 2025 · Filed Nov 17, 2025
CEO purchased ~$13K of CRVO shares in the open marketSourceInsider trade · Traded Nov 13, 2025 · Filed Nov 17, 2025
Director purchased ~$33K of CRVO shares in the open marketSourceInsider trade · Traded Nov 14, 2025 · Filed Nov 17, 2025
Director purchased ~$13K of CRVO shares in the open marketSourceInsider trade · Traded Nov 14, 2025 · Filed Nov 17, 2025
Director purchased ~$13K of CRVO shares in the open marketSourceInsider trade · Traded Nov 12, 2025 · Filed Nov 13, 2025
CFO purchased ~$26K of CRVO shares in the open marketSourceInsider trade · Traded Nov 12, 2025 · Filed Nov 13, 2025
CEO purchased ~$41K of CRVO shares in the open marketSourceInsider trade · Traded Nov 12, 2025 · Filed Nov 13, 2025
Director purchased ~$41K of CRVO shares in the open marketSourceInsider trade · Traded May 14, 2025 · Filed May 14, 2025
CFO purchased ~$36K of CRVO shares in the open marketSource